Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Mediterranean diets and prodromal Parkinson's disease: A causal line, or a confound circle?

Postuma RB.

Mov Disord. 2018 Nov 6. doi: 10.1002/mds.27538. [Epub ahead of print] No abstract available.

PMID:
30398674
2.

White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients.

Dadar M, Zeighami Y, Yau Y, Fereshtehnejad SM, Maranzano J, Postuma RB, Dagher A, Collins DL.

Neuroimage Clin. 2018 Sep 27;20:892-900. doi: 10.1016/j.nicl.2018.09.025. [Epub ahead of print]

3.

Algorithmic Complexity of EEG for Prognosis of Neurodegeneration in Idiopathic Rapid Eye Movement Behavior Disorder (RBD).

Ruffini G, Ibañez D, Kroupi E, Gagnon JF, Montplaisir J, Postuma RB, Castellano M, Soria-Frisch A.

Ann Biomed Eng. 2018 Aug 30. doi: 10.1007/s10439-018-02112-0. [Epub ahead of print]

PMID:
30167913
4.

REM sleep behaviour disorder.

Dauvilliers Y, Schenck CH, Postuma RB, Iranzo A, Luppi PH, Plazzi G, Montplaisir J, Boeve B.

Nat Rev Dis Primers. 2018 Aug 30;4(1):19. doi: 10.1038/s41572-018-0016-5. Review.

PMID:
30166532
5.

Movement disorder society criteria for clinically established early Parkinson's disease.

Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, Obeso J, Oertel W, Olanow CW, Poewe W, Rios-Romenets S, Schäffer E, Seppi K, Heim B, Slow E, Stern M, Bledsoe IO, Deuschl G, Postuma RB.

Mov Disord. 2018 Oct;33(10):1643-1646. doi: 10.1002/mds.27431. Epub 2018 Aug 25.

PMID:
30145841
6.

Validation of the MDS clinical diagnostic criteria for Parkinson's disease.

Postuma RB, Poewe W, Litvan I, Lewis S, Lang AE, Halliday G, Goetz CG, Chan P, Slow E, Seppi K, Schaffer E, Rios-Romenets S, Mi T, Maetzler C, Li Y, Heim B, Bledsoe IO, Berg D.

Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.

PMID:
30145797
7.

Autonomic Sweat Responses in REM Sleep Behavior Disorder and Parkinsonism.

Al-Qassabi A, Pelletier A, Fereshtehnejad SM, Postuma RB.

J Parkinsons Dis. 2018;8(3):463-468. doi: 10.3233/JPD-181357.

PMID:
30040743
8.

The GBA p.Trp378Gly mutation is a probable French-Canadian founder mutation causing Gaucher disease and synucleinopathies.

Ruskey JA, Zhou S, Santiago R, Franche LA, Alam A, Roncière L, Spiegelman D, Fon EA, Trempe JF, Kalia LV, Postuma RB, Dupre N, Rivard GE, Assouline S, Amato D, Gan-Or Z.

Clin Genet. 2018 Oct;94(3-4):339-345. doi: 10.1111/cge.13405. Epub 2018 Jul 16.

PMID:
29920646
9.

Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder.

Li J, Ruskey JA, Arnulf I, Dauvilliers Y, Hu MTM, Högl B, Leblond CS, Zhou S, Ambalavanan A, Ross JP, Bourassa CV, Spiegelman D, Laurent SB, Stefani A, Charley Monaca C, Cochen De Cock V, Boivin M, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Labbe C, Ferman TJ, Dion PA, Fan D, Desautels A, Gagnon JF, Dupré N, Fon EA, Montplaisir JY, Boeve BF, Postuma RB, Rouleau GA, Ross OA, Gan-Or Z.

Mov Disord. 2018 Jul;33(6):1016-1020. doi: 10.1002/mds.27385. Epub 2018 May 14.

PMID:
29756641
10.

Longstanding disease-free survival in idiopathic REM sleep behavior disorder: Is neurodegeneration inevitable?

Yao C, Fereshtehnejad SM, Dawson BK, Pelletier A, Gan-Or Z, Gagnon JF, Montplaisir JY, Postuma RB.

Parkinsonism Relat Disord. 2018 Sep;54:99-102. doi: 10.1016/j.parkreldis.2018.04.010. Epub 2018 Apr 4.

PMID:
29724601
11.

Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial.

Lipsmeier F, Taylor KI, Kilchenmann T, Wolf D, Scotland A, Schjodt-Eriksen J, Cheng WY, Fernandez-Garcia I, Siebourg-Polster J, Jin L, Soto J, Verselis L, Boess F, Koller M, Grundman M, Monsch AU, Postuma RB, Ghosh A, Kremer T, Czech C, Gossens C, Lindemann M.

Mov Disord. 2018 Aug;33(8):1287-1297. doi: 10.1002/mds.27376. Epub 2018 Apr 27.

12.

Cortical and subcortical gray matter bases of cognitive deficits in REM sleep behavior disorder.

Rahayel S, Postuma RB, Montplaisir J, Génier Marchand D, Escudier F, Gaubert M, Bourgouin PA, Carrier J, Monchi O, Joubert S, Blanc F, Gagnon JF.

Neurology. 2018 May 15;90(20):e1759-e1770. doi: 10.1212/WNL.0000000000005523. Epub 2018 Apr 18.

PMID:
29669906
13.

How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder.

Génier Marchand D, Postuma RB, Escudier F, De Roy J, Pelletier A, Montplaisir J, Gagnon JF.

Ann Neurol. 2018 May;83(5):1016-1026. doi: 10.1002/ana.25239. Epub 2018 May 16.

PMID:
29665124
14.

Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts.

Dawson BK, Fereshtehnejad SM, Anang JBM, Nomura T, Rios-Romenets S, Nakashima K, Gagnon JF, Postuma RB.

JAMA Neurol. 2018 Jun 1;75(6):704-710. doi: 10.1001/jamaneurol.2018.0254.

PMID:
29582054
15.

LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder.

Ouled Amar Bencheikh B, Ruskey JA, Arnulf I, Dauvilliers Y, Monaca CC, De Cock VC, Gagnon JF, Spiegelman D, Hu MTM, Högl B, Stefani A, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Mollenhauer B, Sixel-Döring F, Trenkwalder C, Oertel W, Montplaisir JY, Postuma RB, Rouleau GA, Gan-Or Z.

Parkinsonism Relat Disord. 2018 Jul;52:98-101. doi: 10.1016/j.parkreldis.2018.03.019. Epub 2018 Mar 21.

PMID:
29576439
16.

Sleep disorders and Parkinson disease; lessons from genetics.

Gan-Or Z, Alcalay RN, Rouleau GA, Postuma RB.

Sleep Med Rev. 2018 Oct;41:101-112. doi: 10.1016/j.smrv.2018.01.006. Epub 2018 Jan 31. Review.

PMID:
29449121
17.

Prospective memory in idiopathic REM sleep behavior disorder with or without mild cognitive impairment: a preliminary study.

Marcone S, Gagnon JF, Desjardins C, David AC, Postuma RB, Montplaisir J, Joubert S, Rouleau I.

Clin Neuropsychol. 2018 Feb 7:1-23. doi: 10.1080/13854046.2018.1435825. [Epub ahead of print]

PMID:
29411691
18.

A clinical-anatomical signature of Parkinson's disease identified with partial least squares and magnetic resonance imaging.

Zeighami Y, Fereshtehnejad SM, Dadar M, Collins DL, Postuma RB, Mišić B, Dagher A.

Neuroimage. 2017 Dec 19. pii: S1053-8119(17)31074-1. doi: 10.1016/j.neuroimage.2017.12.050. [Epub ahead of print] Review.

PMID:
29277406
19.

Domperidone for Hypotension in Parkinson's Disease: A Systematic Review.

Bacchi S, Chim I, Kramer P, Postuma RB.

J Parkinsons Dis. 2017;7(4):603-617. doi: 10.3233/JPD-171209. Review.

PMID:
29103053
20.

Association Between Poor Cognitive Functioning and Risk of Incident Parkinsonism: The Rotterdam Study.

Darweesh SKL, Wolters FJ, Postuma RB, Stricker BH, Hofman A, Koudstaal PJ, Ikram MK, Ikram MA.

JAMA Neurol. 2017 Dec 1;74(12):1431-1438. doi: 10.1001/jamaneurol.2017.2248.

21.

Caffeine as symptomatic treatment for Parkinson disease (Café-PD): A randomized trial.

Postuma RB, Anang J, Pelletier A, Joseph L, Moscovich M, Grimes D, Furtado S, Munhoz RP, Appel-Cresswell S, Moro A, Borys A, Hobson D, Lang AE.

Neurology. 2017 Oct 24;89(17):1795-1803. doi: 10.1212/WNL.0000000000004568. Epub 2017 Sep 27.

22.

Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.

Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ.

Mov Disord. 2017 Sep;32(9):1264-1310. doi: 10.1002/mds.27115. Review.

23.

Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson's Disease.

Law C, Chriqui E, Kergoat MJ, Leclerc BS, Panisset M, Irving EL, Postuma RB, Chouinard S, Kergoat H.

Can J Neurol Sci. 2017 Sep;44(5):562-566. doi: 10.1017/cjn.2017.39.

PMID:
28862105
24.

Nonmotor Aspects of Parkinson's Disease-How Do They Help Diagnosis?

Postuma RB.

Int Rev Neurobiol. 2017;133:519-539. doi: 10.1016/bs.irn.2017.04.002. Epub 2017 Jun 7. Review.

PMID:
28802931
25.

Dementia with Lewy bodies: Diagnosis is only skin deep?

Postuma RB, Walker Z.

Neurology. 2017 Jul 25;89(4):310-311. doi: 10.1212/WNL.0000000000004163. Epub 2017 Jun 30. No abstract available.

PMID:
28667177
26.

Insomnia and somnolence in idiopathic RBD: a prospective cohort study.

Postuma RB, Gagnon JF, Pelletier A, Montplaisir JY.

NPJ Parkinsons Dis. 2017 Mar 20;3:9. doi: 10.1038/s41531-017-0011-7. eCollection 2017.

27.

Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.

Shafieesabet A, Fereshtehnejad SM, Shafieesabet A, Delbari A, Baradaran HR, Postuma RB, Lökk J.

Parkinsonism Relat Disord. 2017 Sep;42:1-11. doi: 10.1016/j.parkreldis.2017.06.006. Epub 2017 Jun 15. Review.

PMID:
28647434
28.

REM Sleep Behavior Disorder and Cognitive Impairment in Parkinson's Disease.

Jozwiak N, Postuma RB, Montplaisir J, Latreille V, Panisset M, Chouinard S, Bourgouin PA, Gagnon JF.

Sleep. 2017 Aug 1;40(8). doi: 10.1093/sleep/zsx101.

29.

Dopaminergic Imaging and Prodromal Parkinson Disease: A Key Biomarker Arrives.

Postuma RB.

JAMA Neurol. 2017 Aug 1;74(8):901-903. doi: 10.1001/jamaneurol.2017.0846. No abstract available.

PMID:
28595262
30.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

31.

Abnormal Gray Matter Shape, Thickness, and Volume in the Motor Cortico-Subcortical Loop in Idiopathic Rapid Eye Movement Sleep Behavior Disorder: Association with Clinical and Motor Features.

Rahayel S, Postuma RB, Montplaisir J, Bedetti C, Brambati S, Carrier J, Monchi O, Bourgouin PA, Gaubert M, Gagnon JF.

Cereb Cortex. 2018 Feb 1;28(2):658-671. doi: 10.1093/cercor/bhx137.

PMID:
28591814
32.

The New Diagnostic Criteria for Parkinson's Disease.

Postuma RB, Berg D.

Int Rev Neurobiol. 2017;132:55-78. doi: 10.1016/bs.irn.2017.01.008. Epub 2017 Mar 3. Review.

PMID:
28554421
33.

Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.

Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB.

Brain. 2017 Jul 1;140(7):1959-1976. doi: 10.1093/brain/awx118.

PMID:
28549077
34.

Sleep Disorders and RBD: What Would James Parkinson Think?

Postuma RB.

Mov Disord. 2017 May;32(5):705-707. doi: 10.1002/mds.27030. No abstract available.

PMID:
28513080
35.

Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.

Pilotto A, Heinzel S, Suenkel U, Lerche S, Brockmann K, Roeben B, Schaeffer E, Wurster I, Yilmaz R, Liepelt-Scarfone I, von Thaler AK, Metzger FG, Eschweiler GW, Postuma RB, Maetzler W, Berg D.

Mov Disord. 2017 Jul;32(7):1025-1034. doi: 10.1002/mds.27035. Epub 2017 May 16.

PMID:
28509336
36.

Sleep Disturbances in the Prodromal Stage of Parkinson Disease.

Al-Qassabi A, Fereshtehnejad SM, Postuma RB.

Curr Treat Options Neurol. 2017 Jun;19(6):22. doi: 10.1007/s11940-017-0458-1. Review.

PMID:
28466429
37.

Validation of the MDS research criteria for prodromal Parkinson's disease: Longitudinal assessment in a REM sleep behavior disorder (RBD) cohort.

Fereshtehnejad SM, Montplaisir JY, Pelletier A, Gagnon JF, Berg D, Postuma RB.

Mov Disord. 2017 Jun;32(6):865-873. doi: 10.1002/mds.26989. Epub 2017 Apr 21.

PMID:
28429825
38.

Heterozygous PINK1 p.G411S in rapid eye movement sleep behaviour disorder.

Gan-Or Z, Ruskey JA, Spiegelman D, Arnulf I, Dauvilliers Y, Högl B, Monaca-Charley C, Postuma RB, Montplaisir JY, Rouleau GA.

Brain. 2017 Jun 1;140(6):e32. doi: 10.1093/brain/awx076. No abstract available.

PMID:
28379291
39.

Detecting the Cognitive Prodrome of Dementia with Lewy Bodies: A Prospective Study of REM Sleep Behavior Disorder.

Génier Marchand D, Montplaisir J, Postuma RB, Rahayel S, Gagnon JF.

Sleep. 2017 Jan 1;40(1). doi: 10.1093/sleep/zsw014.

PMID:
28364450
40.

Neurodegeneration in REM sleep behavior disorder: Stratification keeps improving.

Postuma RB, Trenkwalder C.

Neurology. 2017 Apr 18;88(16):1486-1487. doi: 10.1212/WNL.0000000000003850. Epub 2017 Mar 22. No abstract available.

PMID:
28330957
41.

Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?

Fereshtehnejad SM, Postuma RB.

Curr Neurol Neurosci Rep. 2017 Apr;17(4):34. doi: 10.1007/s11910-017-0738-x. Review.

PMID:
28324303
42.

Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk?

Arnaldi D, Antelmi E, St Louis EK, Postuma RB, Arnulf I.

Sleep Med Rev. 2017 Dec;36:82-95. doi: 10.1016/j.smrv.2016.11.002. Epub 2016 Nov 10. Review.

PMID:
28082168
43.

Dementia Predictors in Parkinson Disease: A Validation Study.

Anang JB, Nomura T, Romenets SR, Nakashima K, Gagnon JF, Postuma RB.

J Parkinsons Dis. 2017;7(1):159-162. doi: 10.3233/JPD-160925.

PMID:
27911340
44.

The dementia-associated APOE ε4 allele is not associated with rapid eye movement sleep behavior disorder.

Gan-Or Z, Montplaisir JY, Ross JP, Poirier J, Warby SC, Arnulf I, Strong S, Dauvilliers Y, Leblond CS, Hu MTM, Högl B, Stefani A, Monaca CC, De Cock VC, Boivin M, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Barber TR, Evetts SG, Rolinski M, Dion PA, Desautels A, Gagnon JF, Dupré N, Postuma RB, Rouleau GA.

Neurobiol Aging. 2017 Jan;49:218.e13-218.e15. doi: 10.1016/j.neurobiolaging.2016.10.002. Epub 2016 Oct 13.

PMID:
27814994
45.

Large-scale population screening for prodromal PD: a way forward becomes clear.

Postuma RB, Montplaisir JY.

Sleep Med. 2016 Aug;24:148. doi: 10.1016/j.sleep.2016.07.004. Epub 2016 Jul 25. No abstract available.

PMID:
27568526
46.

Genome-wide association study in essential tremor identifies three new loci.

Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G, Rouleau GA.

Brain. 2016 Dec;139(Pt 12):3163-3169. Epub 2016 Oct 20.

47.

Advances in markers of prodromal Parkinson disease.

Postuma RB, Berg D.

Nat Rev Neurol. 2016 Oct 27;12(11):622-634. doi: 10.1038/nrneurol.2016.152. Review.

PMID:
27786242
48.

Abolishing the 1-year rule: How much evidence will be enough?

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G.

Mov Disord. 2016 Nov;31(11):1623-1627. doi: 10.1002/mds.26796. Epub 2016 Sep 26. No abstract available.

PMID:
27666574
49.

Clinical Utility of the Envelope Task in Mild Cognitive Impairment and Dementia.

Marcone S, Gagnon JF, Lecomte S, Imbeault H, Limoges F, Postuma RB, Bertrand JA, Joubert S, Rouleau I.

Can J Neurol Sci. 2017 Jan;44(1):9-16. doi: 10.1017/cjn.2016.298. Epub 2016 Sep 26.

PMID:
27665668
50.

Resting state MRI: a new marker of prodromal neurodegeneration?

Postuma RB.

Brain. 2016 Aug;139(Pt 8):2106-8. doi: 10.1093/brain/aww131. No abstract available.

PMID:
27457227

Supplemental Content

Loading ...
Support Center